| 000 | 01591 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516140219.0 | ||
| 264 | 0 | _c20130422 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1558-3171 | ||
| 024 | 7 |
_a10.1016/j.suc.2012.12.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHernandez-Aya, Leonel F | |
| 245 | 0 | 0 |
_aAdjuvant systemic therapies in breast cancer. _h[electronic resource] |
| 260 |
_bThe Surgical clinics of North America _cApr 2013 |
||
| 300 |
_a473-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnthracyclines _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAromatase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMastectomy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
| 650 | 0 | 4 | _aTrastuzumab |
| 700 | 1 | _aGonzalez-Angulo, Ana M | |
| 773 | 0 |
_tThe Surgical clinics of North America _gvol. 93 _gno. 2 _gp. 473-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.suc.2012.12.002 _zAvailable from publisher's website |
| 999 |
_c22557077 _d22557077 |
||